Table 3

Quality of Life for treatment group compared to control group before and after clinical study

Before ( ± S)

After ( ± S)

Items

Treatment

(n = 44)

Control

(n = 45)

P Value

Treatment

(n = 44)

Control

(n = 45)

P Value

PF

50.57 ± 25.00

52.44 ± 25.97

0.729

61.82 ± 26.31*

55.78 ± 25.69

0.276

PHP

40.10 ± 6.05

43.76 ± 6.52

0.690

54.55 ± 40.22*

58.89 ± 42#

0.636

BP

50.82 ± 14.36

51.64 ± 15.92

0.798

64.07 ± 14.22*

55.76 ± 18.00

0.020

VT

54.55 ± 15.58

58.78 ± 14.89

0.194

58.41 ± 14.21*

61.89 ± 15.79

0.278

SF

73.99 ± 16.24

69.63 ± 17.63

0.229

74.24 ± 13.51

77.28 ± 18.49

0.379

EHP

16.29 ± 19.85

24.81 ± 23.20

0.066

53.03 ± 47.31*

52.60 ± 45.22*

0.965

MH

60.82 ± 13.46

66.40 ± 16.52

0.085

65.64 ± 13.18*

67.91 ± 16.35

0.472

GH

49.54 ± 14.45

52.43 ± 15.94

0.373

61.68 ± 19.68*

61.44 ± 19.85*

0.955

*: P < 0.01;

#: P < 0.05.

PF: physical function (or limitations of activity); PHP, physical health problems; BP, body pain; VT, vitality; SF, social function (or social activities); EHP, emotional health problems, MH, mental health (or energy and emotions); and GH, general health.

Xie et al. Nutrition Journal 2008 7:31   doi:10.1186/1475-2891-7-31